New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
07:19 EDTZMHZimmer Biomet deal very positive, says Bernstein
After Zimmer agreed to buy Biomet, Bernstein thinks the deal will be 17% accretive to cash EPS in the first year and 24% accretive in the second year. The firm expects Zimmer's stock to rise further as a result of the deal, and keeps an Outperform rating on the shares.
News For ZMH From The Last 14 Days
Check below for free stories on ZMH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
06:34 EDTZMHZimmer price target raised to $148 from $119 at Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use